These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 30728860)

  • 1. Contemporary best practice in the use of neoadjuvant chemotherapy in muscle-invasive bladder cancer.
    Marcq G; Jarry E; Ouzaid I; Hermieu JF; Henon F; Fantoni JC; Xylinas E
    Ther Adv Urol; 2019; 11():1756287218823678. PubMed ID: 30728860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Systematic Review and Two-Step Meta-Analysis.
    Yin M; Joshi M; Meijer RP; Glantz M; Holder S; Harvey HA; Kaag M; Fransen van de Putte EE; Horenblas S; Drabick JJ
    Oncologist; 2016 Jun; 21(6):708-15. PubMed ID: 27053504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis of neoadjuvant chemotherapy compared to radical cystectomy alone in improving overall survival of muscle-invasive bladder cancer patients.
    Hamid ARAH; Ridwan FR; Parikesit D; Widia F; Mochtar CA; Umbas R
    BMC Urol; 2020 Oct; 20(1):158. PubMed ID: 33054762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant Chemotherapy Before Radical Cystectomy: Why We Must Adhere?
    Calò B; Marchioni M; Sanguedolce F; Falagario UG; Chirico M; Carrieri G; Cormio L
    Curr Drug Targets; 2021; 22(1):14-21. PubMed ID: 32738871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomised phase III study of neoadjuvant chemotherapy with methotrexate, doxorubicin, vinblastine and cisplatin followed by radical cystectomy compared with radical cystectomy alone for muscle-invasive bladder cancer: Japan Clinical Oncology Group Study JCOG0209.
    Kitamura H; Tsukamoto T; Shibata T; Masumori N; Fujimoto H; Hirao Y; Fujimoto K; Kitamura Y; Tomita Y; Tobisu K; Niwakawa M; Naito S; Eto M; Kakehi Y;
    Ann Oncol; 2014 Jun; 25(6):1192-8. PubMed ID: 24669010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standard or accelerated methotrexate, vinblastine, doxorubicin and cisplatin as neoadjuvant chemotherapy for locally advanced urothelial bladder cancer: Does dose intensity matter?
    Pouessel D; Chevret S; Rolland F; Gravis G; Geoffrois L; Roubaud G; Terrisse S; Boyle H; Chevreau C; Dauba J; Moriceau G; Alexandre I; Deplanque G; Chapelle A; Vauleon E; Colau A; Audenet F; Grellety T; Culine S
    Eur J Cancer; 2016 Feb; 54():69-74. PubMed ID: 26724422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant and adjuvant treatments in muscle-invasive bladder cancer: Where are we?
    Osanto S; Álvarez Gómez de Segura C
    Arch Esp Urol; 2020 Dec; 73(10):971-985. PubMed ID: 33269716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin (AMVAC) as neoadjuvant chemotherapy for patients with muscle-invasive transitional cell carcinoma of the bladder.
    Blick C; Hall P; Pwint T; Al-Terkait F; Crew J; Powles T; Macaulay V; Munro N; Douglas D; Kilbey N; Protheroe A; Chester JD
    Cancer; 2012 Aug; 118(16):3920-7. PubMed ID: 22614698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perioperative chemotherapy for muscle invasive bladder cancer.
    Rudzinski JK; Basappa NS; North S
    Curr Opin Support Palliat Care; 2015 Sep; 9(3):249-54. PubMed ID: 26125306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer and Its Impact on Surgical Morbidity and Oncological Outcomes: A Real-World Experience.
    Nguyen TT; Huillard O; Dabi Y; Anract J; Sibony M; Zerbib M; Xylinas E
    Front Surg; 2018; 5():58. PubMed ID: 30283787
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of neoadjuvant chemotherapy among patients undergoing radical cystectomy for variant histology bladder cancer: A systematic review.
    Alvarez-Maestro M; Chierigo F; Mantica G; Quesada-Olarte JM; Carrion DM; Gomez-Rivas J; Pinto-Marin A; Aguilera Bazan A; Martinez-Piñeiro L
    Arab J Urol; 2022; 20(1):1-13. PubMed ID: 35223104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemotherapy for deep muscle-invasive transitional cell bladder carcinoma - a practice guideline.
    Segal R; Winquist E; Lukka H; Chin JL; Brundage M; Markman BR;
    Can J Urol; 2002 Oct; 9(5):1625-33. PubMed ID: 12431323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant chemotherapy with dose dense MVAC is associated with improved survival after radical cystectomy compared to other cytotoxic regimens: A tertiary center experience.
    Lemiński A; Kaczmarek K; Byrski T; Słojewski M
    PLoS One; 2021; 16(11):e0259526. PubMed ID: 34731219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes Following Clinical Complete Response to Neoadjuvant Chemotherapy for Muscle-invasive Urothelial Carcinoma of the Bladder in Patients Refusing Radical Cystectomy.
    Robins D; Matulay J; Lipsky M; Meyer A; Ghandour R; DeCastro G; Anderson C; Drake C; Benson M; McKiernan JM
    Urology; 2018 Jan; 111():116-121. PubMed ID: 29032239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Oncologic Outcomes of Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin (ddMVAC) with Gemcitabine and Cisplatin (GC) as Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Systematic Review and Meta-Analysis.
    Chung DY; Kang DH; Kim JW; Ha JS; Kim DK; Cho KS
    Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34199565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of gemcitabine and cisplatin as neoadjuvant chemotherapy in muscle invasive bladder cancer: Experience over the last decade.
    Goel S; Sinha RJ; Bhaskar V; Aeron R; Sharma A; Singh V
    Asian J Urol; 2019 Jul; 6(3):222-229. PubMed ID: 31297313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective analysis of the efficacy of two cycles of M-VAC neoadjuvant chemotherapy followed by radical cystectomy for muscle-invasive bladder cancer.
    Kitagawa Y; Izumi K; Miwa S; Kadono Y; Konaka H; Mizokami A; Namiki M
    Anticancer Res; 2013 Oct; 33(10):4497-503. PubMed ID: 24123021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Administration of neoadjuvant chemotherapy for muscle-invasive bladder cancer in real life: Are urologists still too cautious?
    Such M; Lavolle A; Popelin MB; Thibault C; Fontaine E; Dariane C; Oudard S; Mejean A; Timsit MO; Audenet F
    Prog Urol; 2021 May; 31(6):332-339. PubMed ID: 33468415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curative Effect and Survival Assessment Comparing Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin and Cisplatin as Neoadjuvant Therapy for Bladder Cancer: A Systematic Review and Meta-Analysis.
    Wu T; Wu Y; Chen S; Wu J; Zhu W; Liu H; Chen M; Xu B
    Front Oncol; 2021; 11():678896. PubMed ID: 34900663
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.